Miami Myeloma MRD Meeting 2023

Event Description
This workshop is hosted by the Sylvester Comprehensive Cancer Center’s Myeloma Research Institute, in collaboration with HealthTree Foundation for Multiple Myeloma, the Multiple Myeloma Research Foundation (MMRF) and the International Myeloma Foundation (IMF). VJHemOnc is pleased to be official media partner of the workshop.
This meeting will bring together leading experts in multiple myeloma to discuss the use of measurable residual disease (MRD) in clinical and trial settings, and will feature several opportunities for interactive discussion including a live fireside chat with an FDA representative.
Full agenda: https://www.vjhemonc.com/feature/miami-myeloma-mrd-meeting-2023/
Please apply for registration by filling in the form and confirming your details and then we will get back to you.
This meeting is supported by AbbVie, Adaptive, Amgen, CRISPR Therapeutics, GSK, Pfizer and Oncopeptides.
Schedule & Agenda
Speakers & Moderators
Join the Conversation
This event is part of the Lab Values and Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org







Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.